Update to a randomized controlled trial of lutetium-177-PSMA in Oligo-metastatic hormone-sensitive prostate cancer: the BULLSEYE trial

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1745-6215

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Update to a randomized controlled trial of lutetium-177-PSMA in Oligo-metastatic hormone-sensitive prostate cancer: the BULLSEYE trial ; volume:22 ; number:1 ; day:4 ; month:11 ; year:2021 ; pages:1-4 ; date:12.2021
Trials ; 22, Heft 1 (4.11.2021), 1-4, 12.2021

Creator: Privé, Bastiaan M.
Janssen, Marcel J. R.
Oort, Inge M. van
Muselaers, Constantijn H. J.
Jonker, Marianne A.
Gemert, Willemijn A. van
Groot, Michel de
Westdorp, Harm
Mehra, Niven
Verzijlbergen, J. Fred
Scheenen, Tom W. J.
Zámecnik, Patrik
Barentsz, Jelle O.
Gotthardt, Martin
Noordzij, Walter
Vogel, Wouter V.
Bergman, Andries M.
Poel, Henk G. van der
Vis, André N.
Oprea-Lager, Daniela E.
Gerritsen, Winald R.
Witjes, J. Alfred
Nagarajah, James

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13063-021-05733-4

URN: urn:nbn:de:101:1-2022011818234185987475

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.06.20242041, 11:23 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Privé, Bastiaan M.
Janssen, Marcel J. R.
Oort, Inge M. van
Muselaers, Constantijn H. J.
Jonker, Marianne A.
Gemert, Willemijn A. van
Groot, Michel de
Westdorp, Harm
Mehra, Niven
Verzijlbergen, J. Fred
Scheenen, Tom W. J.
Zámecnik, Patrik
Barentsz, Jelle O.
Gotthardt, Martin
Noordzij, Walter
Vogel, Wouter V.
Bergman, Andries M.
Poel, Henk G. van der
Vis, André N.
Oprea-Lager, Daniela E.
Gerritsen, Winald R.
Witjes, J. Alfred
Nagarajah, James
SpringerLink (Online service)

Other Objects (12)

Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial

Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease

Is Further Evaluation of Areas with Faint MDP Uptake Needed in Individuals with Oligo-Metastatic Prostatic Adenocarcinoma?

EUS-guided radiofrequency ablation of pancreatic/peripancreatic tumors and oligo-metastatic disease: an observational prospective multicentric study

Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trial

Long-term outcomes of SBRT for PSMA PET detected oligometastatic prostate cancer

Oligo-metastatic neoPlasms from the gastro-intestinal tract: iDentIfiCaTIon of cliNical and molecular drivers: the PREDICTION study

Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease

Neurologically asymptomatic cerebral oligometastatic prostate carcinoma metastasis identified on [Ga]Ga-THP-PSMA PET/CT

Oligometastatic Prostate Cancer

Correction to: Neurologically asymptomatic cerebral oligometastatic prostate carcinoma metastasis identified on [Ga]Ga-THP-PSMA PET/CT

A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)

Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial

Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease

Is Further Evaluation of Areas with Faint MDP Uptake Needed in Individuals with Oligo-Metastatic Prostatic Adenocarcinoma?

EUS-guided radiofrequency ablation of pancreatic/peripancreatic tumors and oligo-metastatic disease: an observational prospective multicentric study

Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trial

Long-term outcomes of SBRT for PSMA PET detected oligometastatic prostate cancer

Oligo-metastatic neoPlasms from the gastro-intestinal tract: iDentIfiCaTIon of cliNical and molecular drivers: the PREDICTION study

Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease

Neurologically asymptomatic cerebral oligometastatic prostate carcinoma metastasis identified on [Ga]Ga-THP-PSMA PET/CT

Oligometastatic Prostate Cancer

Correction to: Neurologically asymptomatic cerebral oligometastatic prostate carcinoma metastasis identified on [Ga]Ga-THP-PSMA PET/CT

A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)

Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial

Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease

Is Further Evaluation of Areas with Faint MDP Uptake Needed in Individuals with Oligo-Metastatic Prostatic Adenocarcinoma?

EUS-guided radiofrequency ablation of pancreatic/peripancreatic tumors and oligo-metastatic disease: an observational prospective multicentric study

Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trial

Long-term outcomes of SBRT for PSMA PET detected oligometastatic prostate cancer

Oligo-metastatic neoPlasms from the gastro-intestinal tract: iDentIfiCaTIon of cliNical and molecular drivers: the PREDICTION study

Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease

Neurologically asymptomatic cerebral oligometastatic prostate carcinoma metastasis identified on [Ga]Ga-THP-PSMA PET/CT

Oligometastatic Prostate Cancer

Correction to: Neurologically asymptomatic cerebral oligometastatic prostate carcinoma metastasis identified on [Ga]Ga-THP-PSMA PET/CT

A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Update to a randomized controlled trial of lutetium-177-PSMA in Oligo-metastatic hormone-sensitive prostate cancer: the BULLSEYE trial

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial

Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease

Is Further Evaluation of Areas with Faint MDP Uptake Needed in Individuals with Oligo-Metastatic Prostatic Adenocarcinoma?

EUS-guided radiofrequency ablation of pancreatic/peripancreatic tumors and oligo-metastatic disease: an observational prospective multicentric study

Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trial

Long-term outcomes of SBRT for PSMA PET detected oligometastatic prostate cancer

Oligo-metastatic neoPlasms from the gastro-intestinal tract: iDentIfiCaTIon of cliNical and molecular drivers: the PREDICTION study

Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease

Neurologically asymptomatic cerebral oligometastatic prostate carcinoma metastasis identified on [Ga]Ga-THP-PSMA PET/CT

Oligometastatic Prostate Cancer

Correction to: Neurologically asymptomatic cerebral oligometastatic prostate carcinoma metastasis identified on [Ga]Ga-THP-PSMA PET/CT

A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)

Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial

Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease

Is Further Evaluation of Areas with Faint MDP Uptake Needed in Individuals with Oligo-Metastatic Prostatic Adenocarcinoma?

EUS-guided radiofrequency ablation of pancreatic/peripancreatic tumors and oligo-metastatic disease: an observational prospective multicentric study

Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trial

Long-term outcomes of SBRT for PSMA PET detected oligometastatic prostate cancer

Oligo-metastatic neoPlasms from the gastro-intestinal tract: iDentIfiCaTIon of cliNical and molecular drivers: the PREDICTION study

Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease

Neurologically asymptomatic cerebral oligometastatic prostate carcinoma metastasis identified on [Ga]Ga-THP-PSMA PET/CT

Oligometastatic Prostate Cancer

Correction to: Neurologically asymptomatic cerebral oligometastatic prostate carcinoma metastasis identified on [Ga]Ga-THP-PSMA PET/CT

A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)

Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial

Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease

Is Further Evaluation of Areas with Faint MDP Uptake Needed in Individuals with Oligo-Metastatic Prostatic Adenocarcinoma?

EUS-guided radiofrequency ablation of pancreatic/peripancreatic tumors and oligo-metastatic disease: an observational prospective multicentric study

Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trial

Long-term outcomes of SBRT for PSMA PET detected oligometastatic prostate cancer

Oligo-metastatic neoPlasms from the gastro-intestinal tract: iDentIfiCaTIon of cliNical and molecular drivers: the PREDICTION study

Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease

Neurologically asymptomatic cerebral oligometastatic prostate carcinoma metastasis identified on [Ga]Ga-THP-PSMA PET/CT

Oligometastatic Prostate Cancer

Correction to: Neurologically asymptomatic cerebral oligometastatic prostate carcinoma metastasis identified on [Ga]Ga-THP-PSMA PET/CT

A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)

Related objects

Reset password